Introduction
============

Seminal studies in the 60s using \[3H\]-thymidine autoradiographic labeling by Altman and Das were the first to report the generation of new neuronal cells in the adult rodent dentate gyrus (DG), and cell proliferation in the ventricular zone, migration and persisting neurogenesis in the adult olfactory bulb (OB) ([@b2-ndt-3-753]; [@b1-ndt-3-753]). However, these studies had little impact, because of the paucity of cells labeled and the difficulty of definitively identifying them. It was not until the 1990s, with the advent of new procedures for labeling dividing cells in the CNS, like bromodeoxyuridine (BrdU) ([@b35-ndt-3-753]; [@b53-ndt-3-753]) and retroviral labelings ([@b81-ndt-3-753]), that neurogenesis in the SVZ and DG really became accepted ([@b34-ndt-3-753]; [@b76-ndt-3-753]). Though over the past decades, significant progresses have been made in the field of adult neurogenesis and NSCs, there is much debate, controversies and questions to be answered.

Adult neurogenesis, facts, and debates
======================================

Neurogenesis in the adult mammalian brain
-----------------------------------------

Neurogenesis occurs primarily in two areas of the adult brain in mammals: the DG of the hippocampus and the subventricular zone (SVZ) in several species, including human ([@b20-ndt-3-753]; [@b15-ndt-3-753]). In the DG, newly generated neuronal cells in the subgranular zone (SGZ) migrate to the granular layer, where they differentiate into mature neuronal cells, and extend axonal projections to the CA3 area in rodents and primates. In the SVZ, cells are generated in the anterior part of the SVZ and migrate to the OB, through the rostro-migratory stream (RMS), where they differentiate into interneurons of the OB in rodent and non-human primates ([@b76-ndt-3-753]). Newly generated neuronal cells establish functional connections with neighboring cells ([@b81-ndt-3-753]; [@b12-ndt-3-753]), particularly GAB-Aergic innervations in the DG, soon after their migration is completed ([@b82-ndt-3-753]). As many as 9,000 new neuronal cells -- or 0.1% of the granule cell population -- are generated per day in the DG of mice, and 65%--75% of the bulbar neurons are replaced during a 6 weeks period in young adult rats ([@b41-ndt-3-753]; [@b40-ndt-3-753]; [@b11-ndt-3-753]). Among them, a significant proportion undergoes programmed cell death rather than achieving maturity ([@b56-ndt-3-753]; [@b11-ndt-3-753]; [@b33-ndt-3-753]).

The newly generated neuronal cells that survived to maturity may be very stable, and may permanently replace cells born during development, as adult-generated neuronal cells have been reported to survive for extended period of time (eg, for at least 2 years in human DG) ([@b2-ndt-3-753]; [@b20-ndt-3-753]; [@b17-ndt-3-753]; [@b42-ndt-3-753]). Neurogenesis may also occur, albeit at lower levels, in other areas of the mammalian brain, like the Ammon's horn CA1, neocortex, and substantia nigra (SN) ([@b31-ndt-3-753]; [@b67-ndt-3-753]; [@b87-ndt-3-753]). However, some of these reports have been contradicted by other studies ([@b45-ndt-3-753]; [@b49-ndt-3-753]; [@b23-ndt-3-753]; [@b29-ndt-3-753]). Hence, the bulk of evidence suggests that there is little if any neurogenesis going on constitutively in other brain regions.

Stem cells in the adult brain
-----------------------------

The origin of newly generated neuronal cells in the adult brain remains the source of controversies. One theory contends that they originate from differentiated ependymal cells in the lateral ventricle, while another contends that they originate from astrocyte-like cells in the SVZ and SGZ ([@b76-ndt-3-753]). A glial origin for adult generated neuronal cell receives further support recently ([@b22-ndt-3-753]; [@b25-ndt-3-753]). Hence, the possibility of ependymal origins for NSCs has been has mostly discounted and astrocyte-like cells represent the most accepted model for the source of stem cells of the adult brain.

It is postulated that newly generated neuronal cells originate from residual stem cells in the adult brain. Stem cells are defined by five attributes: proliferation, self-renewal over an extended period of time, generation of a large number of differentiated progeny, maintenance of the homeostasis of the tissue, and regeneration of the tissue following injury ([@b63-ndt-3-753]). NSCs are the self-renewing, multipotent cells that generate neurons, astrocytes, and oligodendrocytes of the nervous system. Neural progenitor cells are, as most broadly defined, any cells that do not fulfill all of the attributes of NSCs. Though NSCs remain to be characterized in the adult CNS, self-renewing, multipotent NSC-like cells have been isolated and characterized in vitro from various areas of the adult CNS, neurogenic and non-neurogenic, including the spinal cord, suggesting that NSC may reside throughout the CNS ([@b76-ndt-3-753]).

There are currently no specific markers of adult NSCs. Nestin, the transcription factors sox-2, oct-3/4, and the RNA-binding protein Musashi 1 are markers for neural progenitor and stem cells, but also label population of glial cells ([@b48-ndt-3-753]; [@b68-ndt-3-753]; [@b18-ndt-3-753]; [@b86-ndt-3-753]; [@b39-ndt-3-753]; [@b44-ndt-3-753]; [@b59-ndt-3-753]), further fueling the controversies over the origin of newly generated neuronal cells in the adult brain.

Rate and modulation
-------------------

The rate of neurogenesis in the rodent DG and SVZ is modulated by various environmental stimuli, physio- and pathological conditions ([@b77-ndt-3-753]). For example, environmental enrichment promotes the survival of newly generated neuronal cells in the DG. Voluntary running stimulates the generation of newly generated neuronal cells in the DG, but not the SVZ. Stress, neuroinflammation and aging decrease neurogenesis in the DG ([@b57-ndt-3-753]; [@b55-ndt-3-753]). In the diseased brain and after injuries to the CNS, like strokes and traumatic brain injuries (TBIs), neurogenesis is stimulated in the neurogenic areas, and new neuronal cells are generated at the sites of injuries, where they replace some of the degenerated nerve cells ([@b36-ndt-3-753]). Cell tracking studies revealed that newly generated neuronal cells at sites of injuries originates from the SVZ. Newly generated neuronal cells migrate partially through the RMS to the degenerated areas. It is estimated that 0.2% of the degenerated nerve cells are replaced in the striatum after focal ischemia ([@b6-ndt-3-753]). Hence, neurogenesis can be stimulated in the injured brain.

Limit and pitfalls of BrdU labeling
-----------------------------------

The modulation of neurogenesis and its quantification have been subject of debates, partly due to the use of BrdU, a thymidine analog, labeling as a method of assessment. As BrdU crosses the blood-brain barrier, it is generally administered intraperiteonally. It is suggested that activity, like exercise, but also the effects of various treatments and physio- and pathological conditions on cerebral flow, metabolism and permeability of the blood-brain barrier to reagents, and in particular to BrdU, may affect the availability of BrdU to the brain. The variation of BrdU quantification observed in these conditions would then reflect the change in BrdU uptake by the cells, rather than the modulation neurogenesis ([@b78-ndt-3-753]).

With regard to the quantification of neurogenesis with BrdU, one study suggests that the standard concentration used to assess neurogenesis (50--100 mg/kg body weight in rodents, intraperitoneal injection) may not label all the dividing cells ([@b78-ndt-3-753]), whereas another study reports that it does ([@b10-ndt-3-753]). Further systematic studies on BrdU labeling in the CNS are thus needed to further define the conditions in which BrdU can be used for studying neurogenesis. The use of BrdU to study neurogenesis carries other limitations, like labeling of DNA repair, abortive cell cycle reentry and gene duplication, without cell proliferation ([@b78-ndt-3-753]). Other strategies are therefore necessary to make educated conclusions with regard to adult neurogenesis when using BrdU labeling, like the study of markers of the cell cycle and use of retroviruses.

Mechanisms underlying adult neurogenesis
----------------------------------------

Most of the mechanisms underlying adult neurogenesis and NSC growth and fate determination are yet to be uncovered. It has been reported that cell death stimulates the proliferation of neural progenitor cells in the adult hippocampus ([@b30-ndt-3-753]). Other studies reveal that the mitotic rate is regulated by the number of available progenitor cells, rather than by cell death ([@b19-ndt-3-753]; [@b38-ndt-3-753]). On the molecular level, epidermal growth factor and basic fibroblast growth factor were the first mitogens to be identified for neural progenitor and stem cells in vitro, and to stimulate neurogenesis in vivo ([@b65-ndt-3-753]; [@b24-ndt-3-753]; [@b14-ndt-3-753]; [@b47-ndt-3-753]). However, other factors present in conditioned medium, like the glycosylated form of the protease inhibitor cystatin C (CCg), are also required for the proliferation of self-renewing, multipotent NSCs from single cells in vitro ([@b75-ndt-3-753]), and remain to be characterized, as well as the pathways of these mitogens and cofactors.

Broader potential of adult stem cells
-------------------------------------

Adult stem cells are multipotents; they generate lineage specific cell types restricted to the tissues from which they are derived. Several studies have reported that adult-derived stem cells, and particularly adult-derived neural progenitor and stem cells, may have a broader potential; ie, they generate cell types of lineages other than their tissues of origin ([@b9-ndt-3-753]; [@b8-ndt-3-753]; [@b51-ndt-3-753]). However though some studies presented convincing results, phenomenon like contamination, transformation, transdifferentiation, and cell fusion have been reported as possible explanation for the phenotypes observed in some studies ([@b4-ndt-3-753]; [@b52-ndt-3-753]).

Function(s) of newborn neuronal cells
-------------------------------------

The function(s) of adult neurogenesis has been the source of intense research and debates. Evidences suggest that newly generated neuronal cells participate to process like learning and memory, and depression ([@b31-ndt-3-753]; [@b73-ndt-3-753]; [@b37-ndt-3-753]; [@b69-ndt-3-753]). The involvement of adult neurogenesis in learning and memory has been challenged by other studies. Increased hippocampal neurogenesis has been observed without improvement of learning and memory performances, in the Morris water maze test, in mice selectively bred for high levels of wheel running ([@b66-ndt-3-753]). Therefore the function of newly generated neuronal cells in the adult brain remains to be determined.

Finally, the evidence that neurogenesis occurs in the adult brain, and that NSCs reside in the adult CNS provide new avenues for cellular therapy. Cell therapeutic intervention may involve the stimulation of endogenous or the transplantation of neural progenitor and stem cells of the adult CNS. However, adult NSCs have yet to be brought to therapy.

Though it is now accepted that neurogenesis occurs in the adult brain and NSCs reside in the adult CNS, much questions and controversies remain to be answered: what is the origin of newly generated neuronal cells in the adult brain, what are their molecular markers, what are the factors and mechanisms controlling NSC growth and fate specification, what is the potential of adult-derived stem cells, what are the functions of newly generated neuronal cells in the adult brain, and how can we use adult NSCs therapeutically?

The future of adult neurogenesis
================================

Newly generated neuronal cells represent a small fraction of nerve cells in the adult brain. But data presented above suggest that their relevance to CNS physio- and pathology, and cellular therapy as significant, but yet to be uncovered. One of the key underlyings of the importance of newly generated neuronal cells is their relative contributions compare to the preexisting network to CNS functioning. One can postulate that such contribution will depend on the specific properties of adult generated neuronal cells.

On the functioning of newly generated neuronal cells in the adult brain
-----------------------------------------------------------------------

Adult newly generated neuronal cells belong to three groups based on their destinies. The first group consists of the newly generated neuronal cells that will undergo post-mitotic death ([@b56-ndt-3-753]; [@b11-ndt-3-753]). The second group represents a population of newly generated cells that neither undergo apoptosis, nor differentiate to a defined fate. This latter group of cells likely contributes to renewing the stem cell niche. Niches are specialized microenvironments that regulate stem cells activity ([@b54-ndt-3-753]; [@b72-ndt-3-753]). In the adult brain, neurogenic niches are maintained in restricted regions and have been identified and characterized ([@b3-ndt-3-753]). These niches, an angiogenic and an astroglial niches, control NSCs self-renewal and differentiation ([@b60-ndt-3-753]; [@b74-ndt-3-753]). It is hypothesized that neurogenic niches underlie the properties and functions of NSCs in the adult CNS ([@b3-ndt-3-753]; [@b79-ndt-3-753]; [@b50-ndt-3-753]). The third group consists of the newly generated neuronal cells that will survive to maturity and integrate the network ([@b2-ndt-3-753]; [@b20-ndt-3-753]; [@b42-ndt-3-753]; [@b17-ndt-3-753]).

Several lines of evidence suggest that newly generated neuronal cells have different properties and physiological functions, than mature nerve cells, that may underlie their specific functions. Young granule cells in the adult DG appear to exhibit robust long-term potentiation that, in contrast to mature granule cells, cannot be inhibited by GABA ([@b84-ndt-3-753]). More recently, newly generated neuronal cells in the adult hippocampus were characterized as receiving GABAergic excitatory input ([@b26-ndt-3-753], [@b27-ndt-3-753]; [@b80-ndt-3-753]), a function of GABA previously reported during development ([@b7-ndt-3-753]). Once cells have matured and integrated the pre-existing network, they may then functionally replace nerve cells born during development. Among the questions that arise from such theory are: What are the physiological functions of the newly generated neural cells during the time they are distinct from their mature counterpart? What is the function of such cellular renewal? Why would it occur only and specifically in discrete areas of the adult brain?

On the functionality of newly generated neuronal cells in the adult brain
-------------------------------------------------------------------------

The increase of neurogenesis in diseases, disorders, and after injuries might then serve a neuroadaptative process ([Figure 1](#f1-ndt-3-753){ref-type="fig"}). Patients with neurological diseases, like Alzheimer's disease, epilepsy, and Parkinson's disease (PD), but also recovering from strokes and injuries, are at greater risk of depression ([@b62-ndt-3-753]; [@b28-ndt-3-753]; [@b70-ndt-3-753]) and present memory impairments ([@b46-ndt-3-753]; [@b83-ndt-3-753]). Since learning and memory, and depression are associated with hippocampal neurogenesis ([@b31-ndt-3-753]; [@b37-ndt-3-753]; [@b73-ndt-3-753]; [@b69-ndt-3-753]), the depressive episode and learning impairments in patients suffering from neurological diseases, or disorders may contribute to the regulation of neurogenesis, in an additive, or cooperative manner with the disorder. Therefore, modulation of neurogenesis in the hippocampus might be an attempt by the CNS to compensate for other neuronal functions associated with the disease, like depression, and learning and memory impairments.

The increase in neurogenesis would also be a factor contributing to the plasticity of the CNS, and particularly related to the recovery in the CNS after injury. After cerebral strokes and TBIs, there is a striking amount of neurological recovery in the following months and years, despite often-permanent structural damage ([@b71-ndt-3-753]; [@b5-ndt-3-753]). Though the mechanisms underlying such recovery are not fully understood, properties of plasticity of the CNS, like the reorganization of the pre-existing network and axonal sprouting have been implicated in the recovery ([@b64-ndt-3-753]; [@b43-ndt-3-753]). Particularly, reorganization of the contra-lateral hemisphere has been involved in plasticity after brain injury ([@b13-ndt-3-753]). Neurogenesis is increased bilaterally in the DG and the SVZ after cerebral strokes and TBIs. The bilateral increase in neurogenesis would contribute to the plasticity related recovery in the CNS, and particularly after injury.

The generation of newly generated neuronal cells at the sites of injury could represent a regenerative attempt by the CNS. In the diseased brain and after injuries to the CNS, new neuronal cells are generated at the sites of degeneration, where they replace some of the lost nerves cells ([@b6-ndt-3-753]). Hence, there is no functional recovery. The generation of new neuronal cells at the sites of injury could represent an attempt by the CNS to regenerate following injury. Several hypotheses can explain the lack of recovery of the CNS after injury. The number of new neurons generated may be too low to compensate for the neuronal loss: 0.2% of the degenerated nerve cells in the striatum after focal ischemia ([@b6-ndt-3-753]). The neuronal cells that are produced are nonfunctional because they do not develop into fully mature neurons, because they do not develop into the right type of neurons, or because they are incapable of integrating into the surviving brain circuitry. Gliogenesis has also been reported to occur at the sites of injuries ([@b21-ndt-3-753]). Therefore, neurogenesis and gliogenesis at the site of injuries may participate to a healing process.

The total number of neurons in the adult brain does not dramatically increase, and cell death is an established process in that adult brain ([@b33-ndt-3-753]). Newly generated neuronal cells may contribute to homeostasis of the tissue. Neurogenic niches have been described in the adult brain, and may hold the molecular and cellular cues to such phenomenon ([@b3-ndt-3-753]). On the physiopathological level, an explanation is yet to be brought. It is worth mentioning that it has been suggested that since environmental enrichment promotes adult neurogenesis, and standard laboratory living condition do not represent physiological environment, neurogenesis may occur more broadly, at low level, that would remain undetected ([@b78-ndt-3-753]), though such eventuality remains to be proven in mammals. Indeed, it has been proposed that self-repair mechanisms may operate in the adult rodent SN ([@b87-ndt-3-753]), the area of the CNS affected in PD. If such turn-over of dopaminergic neuronal cells was confirmed, progression of the disease would then be determined not only by the rate of degeneration of SN neurons, but also by the efficacy in the formation of new dopamine neurons. Thus, disturbances of the equilibrium of cellular homeostasis could result in neurodegenerative diseases. So, in PD, neurogenesis might not only be a process for functional recovery, but it may also play a key role in the pathology of the disease. However, these data remain the source of controversies ([@b49-ndt-3-753]; [@b23-ndt-3-753]), and such hypothesis remains to be demonstrated.

Though at this time these hypotheses remain mostly speculative, the future of adult neurogenesis and NSC research lies in our understanding of the specific role and relative contribution of newly generated neuronal cells to the physio- and pathology of the CNS.

The promise of adult neural stem cells
======================================

The promise of adult NSCs lie also in our ability to bring adult NSC research to therapy. Because of their potential to generate the main phenotype of the CNS, NSCs hold the promise to cure a broad range of CNS diseases and injuries. The confirmation that neurogenesis occurs in the adult brain and NSCs reside in the adult CNS, opens new avenues for cellular therapy. Cell therapeutic intervention may involve the stimulation or grafting of neural progenitor and stem cells ([@b58-ndt-3-753]; [@b85-ndt-3-753]). The generation of new neuronal cells at the sites of injury further highlights the potential of the CNS to repair itself. The SVZ origin of the newly generated neuronal cells suggests that the stimulation of neurogenesis in the SVZ would provide a strategy to promote functional recovery after injury ([@b16-ndt-3-753]). Alternatively, the potential to isolate neural progenitor and stem cells from nondegenerated brain areas from the patient himself would provide an autologous source of transplantable neural progenitor and stem cells, thereby obviating the need to find a matching donor for the tissues and the use of drugs that suppress the immune system; thereby increasing the chance of successful graft and recovery. However such strategy would involve invasive surgery and the destruction of healthy brain tissue, a limiting factor for its clinical application. Neural progenitor and stem cells have also been isolated from human post-mortem tissues, providing an alternative source of tissues for cellular therapy ([@b61-ndt-3-753]).

Conclusion
==========

The promise of the future of adult neurogenesis and NSC research lies in our understanding of the function and relative contribution of newly generated neuronal cells in the adult brain, and our ability to bring adult NSC to therapy. The molecular, cellular, and physiological characterization of adult NSCs is a prerequisite to such endeavor. Significant advances have already been made in just the past decades. Because of the potential of adult neurogenesis and NSCs to redefine brain functioning, physio- and pathology, and its potential to cure a broad range of CNS diseases and injuries, the future of this field of research is tantalizing.
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Adult neurogenesis and neural stem cells. Key publications

  Year   Event (references)
  ------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1965   Seminal studies on adult neurogenesis ([@b2-ndt-3-753])
  1982   Monoclonal antibody against BrdU ([@b35-ndt-3-753])
  1988   BrdU a marker to study neurogenesis ([@b53-ndt-3-753])
  1990   Identification of nestin as a marker for neural progenitor and stem cells ([@b48-ndt-3-753])
  1992   Post-mitotic cell death of newly generated neuronal cells in adult SVZ ([@b56-ndt-3-753])
  1992   Isolation and characterization of neural progenitor and stem cells from the adult rodent SVZ ([@b65-ndt-3-753])
  1995   Isolation and characterization of neural progenitor and stem cells from the adult rodent hippocampus, adult hippocampal-derived neural progenitor, and stem cells grafted in adult brain ([@b24-ndt-3-753])
  1997   Environmental enrichment promotes adult neurogenesis ([@b41-ndt-3-753])
  1998   Characterization of adult neurogenesis in the adult human hippocampus ([@b20-ndt-3-753])
  1999   Broader potential of adult-derived neural progenitor and stem cells ([@b9-ndt-3-753])
  1999   Glial origin for newly generated neural stem cells in the SVZ ([@b18-ndt-3-753])
  2001   Post-mitotic cell death of newly generated neuronal cells in adult hippocampus ([@b11-ndt-3-753])
  2001   Isolation and characterization of neural progenitor and stem cells from human post-mortem tissues and biopsies ([@b61-ndt-3-753])
  2005   Newly generated neuronal cells receive GABAergic excitatory input ([@b80-ndt-3-753])
  2007   Characterization of adult neurogenesis in the adult human SVZ ([@b15-ndt-3-753])
